The Path to a Clear Answer: Imaging and Biopsy
At a Glance
Breast fibrosis is benign scar-like tissue that can look like cancer on mammograms, ultrasound, or MRI. A biopsy helps identify the tissue, but doctors must confirm that the pathology explains the imaging; a mismatch may require more sampling.
When your doctor sees an area of fibrosis (scar-like tissue) on a breast scan, it can be a source of significant stress. This is because fibrosis can “act” exactly like a tumor on imaging, creating shapes and shadows that are very similar to cancer without a tissue sample [1][2].
Why Imaging Can’t Tell the Difference
Fibrosis causes changes in the breast that mimic the “red flags” of cancer. Radiologists use a system called BI-RADS (Breast Imaging Reporting and Data System) to categorize these features. BI-RADS is a risk categorization system, not a final diagnosis. BI-RADS 1 or 2 generally need routine screening, and BI-RADS 3 findings usually require short-interval imaging. Fibrotic features often lead to a BI-RADS 4 (suspicious) or BI-RADS 5 (highly suggestive of malignancy) score, which triggers a biopsy [3].
- Architectural Distortion: Fibrosis can pull and twist the surrounding breast tissue, creating a “starburst” pattern that looks like an invasive tumor on a mammogram [1].
- Posterior Shadowing: On an ultrasound, dense fibrous tissue can block sound waves, creating a dark shadow behind it—a feature often seen in breast cancer [2].
- Enhancement Patterns: On an MRI, some types of fibrosis can “light up” (enhance) with contrast, sometimes showing the same rapid uptake and “washout” seen in malignant tumors [4].
The Role of Biopsy
Because imaging alone is not definitive for suspicious lesions, a biopsy is the standard of care to confirm the area is benign. There are two primary types of image-guided biopsies used for fibrotic areas:
- Core Needle Biopsy (CNB): A hollow needle is used to take several thin “cores” of tissue. This is often used for larger masses visible on ultrasound [5].
- Vacuum-Assisted Biopsy (VAB): This uses a larger needle and gentle suction to collect more tissue through a single small incision. VAB is often utilized based on the lesion target and local expertise, particularly for architectural distortion or tiny calcium deposits (calcifications) [5][6].
What to Expect: During the procedure, your doctor will use local anesthetic to numb the area. You may feel pressure, but you should not feel sharp pain. The doctor will usually place a tiny metallic biopsy marker (or “clip”). This marks the spot for future mammograms, ensuring doctors know exactly where the biopsy was performed [7]. Expect some bruising and aching over the following days, and call your clinic if you experience worsening pain, heavy bleeding, or signs of infection.
Radiologic-Pathologic Concordance
The most critical step in your diagnosis is ensuring that the biopsy result “matches” what was seen on the scan. This is called radiologic-pathologic concordance [8].
- Concordant Benign: The pathology shows a benign condition (like stromal fibrosis) that perfectly explains the suspicious imaging. For example, if the radiologist saw a firm, shadowed mass and the biopsy shows dense, thick collagen, the results “match” [9].
- Discordant Benign: This is a potential red flag. It happens when the biopsy shows something benign, but that finding does not explain the suspicious imaging [8]. For instance, if the imaging looks like a 2cm tumor but the biopsy only shows “mild inflammation,” the doctor must assume the needle might have missed the real target.
- Next Steps for Discordance: If a result is discordant, you should not simply wait and watch. Multidisciplinary review is required, and case-specific additional sampling—often a repeat biopsy or a surgical excision (removing the area)—is usually needed to ensure a cancer wasn’t missed [8][10].
Your Pathology Report Checklist
When you receive your pathology report, focus on asking your care team: “What exact diagnosis did my pathology report make, and does it explain my imaging?”
- [ ] Specific Diagnosis: Does it say “stromal fibrosis”? Be aware that words like “sclerosing adenosis” and “PASH” (pseudoangiomatous stromal hyperplasia) are distinct benign entities, not interchangeable with fibrosis [4][P-85].
- [ ] Target Confirmation: If the biopsy was for “calcifications,” does the report explicitly state that calcifications were found in the tissue sample [9]?
- [ ] Atypia Status: Does the report mention any atypia (abnormal-looking cells)? Finding atypia within an area of fibrosis may change your future screening plan [11].
- [ ] Concordance Statement: Does the report or a follow-up note from the radiologist explicitly state that the results are “concordant” [8]?
Common questions in this guide
What does breast fibrosis mean on a biopsy report?
Why can breast fibrosis lead to a BI-RADS 4 or 5 rating?
How do core needle and vacuum-assisted breast biopsies differ?
Why is a marker clip placed after a breast biopsy?
What does radiologic-pathologic concordance mean after a breast biopsy?
What happens if a benign breast biopsy is discordant with the imaging?
Can atypia in a breast fibrosis biopsy change my follow-up?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.My imaging showed architectural distortion; does the finding of 'stromal fibrosis' on my biopsy fully explain that specific feature?
- 2.Was a biopsy marker placed at the site, and did the post-biopsy imaging confirm it is in the exact center of the area we were worried about?
- 3.Why did you choose a core needle biopsy over a vacuum-assisted biopsy for this specific lesion?
- 4.If my results are 'discordant,' what are the next steps—a repeat biopsy or a surgical excision?
- 5.Does my pathology report show any 'atypia' or signs of 'proliferative' changes that might increase my future risk?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
Breast Fibromatosis: Radiologic-Pathologic Correlation.
Winkler N, Peterson M, Factor R
Journal of breast imaging 2021; (3(5)):597-602 doi:10.1093/jbi/wbab051.
PMID: 38424943 - 2
Stromal fibrosis: imaging features with diagnostic contribution of diffusion-weighted MRI.
Yilmaz R, Bayramoglu Z, Kartal MG, et al.
The British journal of radiology 2018; (91(1085)):20170706 doi:10.1259/bjr.20170706.
PMID: 29388800 - 3
Digital Mammography Stereotactic Biopsy versus Digital Breast Tomosynthesis-guided Biopsy: Differences in Biopsy Targets, Pathologic Results, and Discordance Rates.
Rochat CJ, Baird GL, Lourenco AP
Radiology 2020; (294(3)):518-527 doi:10.1148/radiol.2019191525.
PMID: 31961261 - 4
Fibrocystic Changes of the Breast: Radiologic-Pathologic Correlation of MRI.
Choe AI, Kasales C, Mack J, et al.
Journal of breast imaging 2022; (4(1)):48-55 doi:10.1093/jbi/wbab071.
PMID: 38422411 - 5
Image-guided biopsy of breast lesions-when to use what biopsy technique.
Sanderink WBG, Camps-Herrero J, Athanasiou A, et al.
Insights into imaging 2025; (16(1)):208 doi:10.1186/s13244-025-02084-5.
PMID: 40996584 - 6
Breast Microcalcifications: Diagnostic Outcomes According to Image-Guided Biopsy Method.
Bae S, Yoon JH, Moon HJ, et al.
Korean journal of radiology 2015; (16(5)):996-1005 doi:10.3348/kjr.2015.16.5.996.
PMID: 26357494 - 7
Advantages and Challenges of Using Breast Biopsy Markers.
Alshafeiy TI, Matich A, Rochman CM, Harvey JA
Journal of breast imaging 2022; (4(1)):78-95 doi:10.1093/jbi/wbab052.
PMID: 38422410 - 8
Radiologic-Pathologic Discordance After Image-Guided Breast Biopsy: A Systematic Review of Prevalence and Outcomes.
Yincharoen P, Sharma CP, Tawanwongsri W
Medical sciences (Basel, Switzerland) 2026; (14(2)) doi:10.3390/medsci14020229.
PMID: 42201021 - 9
Stromal Fibrosis of the Breast: A Spectrum of Benign to Malignant Imaging Appearances.
Nassar L, Baassiri A, Salah F, et al.
Radiology research and practice 2019; (2019()):5045908 doi:10.1155/2019/5045908.
PMID: 30886748 - 10
Role of ultrasound-guided vacuum-assisted breast biopsy in the management of radiologic-pathologic discordance: a retrospective single-centre study.
Vatteroni G, Pinna G, Trimboli RM, et al.
La Radiologia medica 2024; (129(10)):1454-1462 doi:10.1007/s11547-024-01864-1.
PMID: 39102107 - 11
Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes.
Quinn EM, Dunne E, Flanagan F, et al.
Breast cancer research and treatment 2020; (183(3)):677-682 doi:10.1007/s10549-020-05806-z.
PMID: 32696314
This page explains how imaging and biopsy are used to evaluate breast fibrosis for informational purposes only and does not constitute medical advice. Your radiologist, pathologist, or breast specialist should interpret your results and recommend follow-up.
Get notified when new evidence is published on breast fibrosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.